WBT-25181-29103 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Dose 1 — Pfizer-BioNTech
2021-01-06
Registered in v-safe
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · None

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-22
Dose 2 — Pfizer-BioNTech
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-29
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-05
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-12
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-19
Survey response — day 28, dose 2
MedDRA: Lymph node pain — Feeling: Good

Free text: Small sore lymph node in armpit of vaccination arm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-26
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-05
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-23
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-23
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-22
Survey response — 12 months, dose 2
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: autoimmune disease that has been in remission for more than a decade is now active

MedDRA releases: 2024-11 · check-in free text available
2022-01-22
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-01-24
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Pfizer-BioNTech
2	2021-01-22	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-01-22	Successful 2022-01-24	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 4 — day 28, dose 2

2021-02-19

Symptoms: Small sore lymph node in armpit of vaccination arm

Release 11 — 12 months, dose 2

2022-01-22

Symptoms: autoimmune disease that has been in remission for more than a decade is now active

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Condition aggravated	·	·	✓
SD	Lymph node pain	✓	✓	✓
SD	Pre-existing disease	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release